Estimating conditional survival for breast, colorectal and thyroid cancer patients
When patients who have survived for a certain period of time after cancer diagnosis wish to know about their prognosis at that specific time, there are few relevant statistics available. Many traditional survival estimates become less accurate in that situation. Conditional survival (CS), which represents the probability that a cancer patient survives additional years, given that the patient has already survived few years, is a clinically more relevant measure of prognosis for cancer survivors. The majority of breast, colorectal, and thyroid cancer patients have excellent prognosis, yet the cancer diagnosis and continued surveillance for 10+ years can cause significant anxiety and stress. Understanding CS can provide these cancer survivors with information for personal health-related planning and treating physicians with information for continuing cancer surveillance. This project will develop CS estimates for breast, colorectal and thyroid cancer patients using registry data from the National Cancer Institute and the National Cancer Database.
Presentation at the ASCO annual science and society meeting; Chicago, IL, June 2014
Presented at the Annual Academic Surgical Congress; Las Vegas, NV, February 2015
Published in the Journal of Surgical Research, 2016
Published in Melanoma Research, 2016
Published in Thyroid, 2014